{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T20:10:03Z","timestamp":1651435803534},"reference-count":10,"publisher":"Japanese Society of Internal Medicine","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Jpn. Soc. Intern. Med","J. Jpn. Soc. Intern. Med."],"published-print":{"date-parts":[[2014]]},"DOI":"10.2169\/naika.103.699","type":"journal-article","created":{"date-parts":[[2015,3,9]],"date-time":"2015-03-09T22:07:32Z","timestamp":1425938852000},"page":"699-704","source":"Crossref","is-referenced-by-count":0,"title":["4. Progress in Lung Cancer Therapy"],"prefix":"10.2169","volume":"103","author":[{"given":"Seiji","family":"Yano","sequence":"first","affiliation":[{"name":"Division of Medical Oncology, Cancer Research Institute, Kanazawa University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Noda K, et al: Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer. N Engl J Med 346: 85-91, 2003.","DOI":"10.1056\/NEJMoa003034"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Scagliotti GV, et al: Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer. J Clin Oncol 26: 3543-3551, 2008.","DOI":"10.1200\/JCO.2007.15.0375"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Sandler A, et al: Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer. N Engl J Med 355: 2542-2550, 2006.","DOI":"10.1056\/NEJMoa061884"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Lynch TJ, et al: Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 350: 2129-2139, 2004.","DOI":"10.1056\/NEJMoa040938"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Mitsudomi T, et al: Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405):an open label, randomised phase 3 trial. Lancet Oncol 11: 121-128, 2010.","DOI":"10.1016\/S1470-2045(09)70364-X"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Maemondo M, et al: Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR. N Engl J Med 362: 2380-2388, 2010.","DOI":"10.1056\/NEJMoa0909530"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7) Soda M, et al: Identification of the transforming <i>EML4-ALK<\/i> fusion gene in non-small-cell lung cancer. Nature 448: 561-566, 2007.","DOI":"10.1038\/nature05945"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Shaw A, et al: Crizotonib versus chemotherapy in advanced ALK-positive lung cancer. N Engl J Med 368: 2385-2394, 2013.","DOI":"10.1056\/NEJMoa1214886"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Takeuchi K, et al: RET, ROS-1, and ALK fusions in lung cancer. Nat Med 18: 378-381, 2013.","DOI":"10.1038\/nm.2658"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Yano S, et al: Ligand-triggered resistance to molecular targeted drugs in lung cancer: roles of HGF and EGFR ligands. Cancer Sci 103: 1663-1671, 2012.","DOI":"10.1111\/j.1349-7006.2012.02279.x"}],"container-title":["Nihon Naika Gakkai Zasshi"],"original-title":["4\uff0e\u80ba\u304c\u3093\u6cbb\u7642\u306e\u9032\u6b69"],"language":"en","deposited":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T19:30:17Z","timestamp":1651433417000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/naika\/103\/3\/103_699\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.2169\/naika.103.699","relation":{},"ISSN":["0021-5384","1883-2083"],"issn-type":[{"value":"0021-5384","type":"print"},{"value":"1883-2083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]}}}